With respect to the mechanisms of ROCK in the presence of TGF-β, a study in human breast cancer cells showed that Rho/ROCK is able to phosphorylate the linker region of Smad3 and thereby alter the effect of TGF-β without affecting carboxy-terminal phosphorylation. This evidence concerns the gene SMAD3 and breast cancer.